Patricia Carr - Feb 27, 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
SVP, Chief Accounting Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr
Stock symbol
JAZZ
Transactions as of
Feb 27, 2025
Transactions value $
-$381,909
Form type
4
Date filed
3/3/2025, 07:21 PM
Previous filing
Jan 22, 2025
Next filing
Mar 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Options Exercise $509K +4.5K +54.63% $113.10 12.7K Feb 27, 2025 Direct
transaction JAZZ Ordinary Shares Sale -$650K -4.5K -35.33% $144.42 8.24K Feb 27, 2025 Direct
transaction JAZZ Ordinary Shares Options Exercise $38.6K +313 +3.8% $123.36 8.55K Feb 27, 2025 Direct
transaction JAZZ Ordinary Shares Sale -$45.2K -313 -3.66% $144.42 8.24K Feb 27, 2025 Direct
transaction JAZZ Ordinary Shares Disposed to Issuer -$52.8K -371 -4.5% $142.43 7.87K Feb 27, 2025 Direct F1
transaction JAZZ Ordinary Shares Disposed to Issuer -$70.8K -497 -6.32% $142.43 7.37K Feb 27, 2025 Direct F1
transaction JAZZ Ordinary Shares Award $0 +2.89K +39.2% $0.00 10.3K Feb 27, 2025 Direct F2
transaction JAZZ Ordinary Shares Sale -$111K -773 -7.54% $143.30 9.49K Feb 28, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -4.5K -100% $0.00 0 Feb 27, 2025 Ordinary Shares 4.5K $113.10 Direct F3
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -313 -100% $0.00 0 Feb 27, 2025 Ordinary Shares 313 $123.36 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
F3 These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise.
F4 These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise.